Quarterly report [Sections 13 or 15(d)]

Consolidated Statements of Cash Flows

v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities    
Net income $ 668 $ 839
Adjustments to reconcile net income to net cash provided by operating activities:    
Unrealized foreign currency exchange loss, net 5 3
Depreciation, amortization and accretion expense 312 302
Share-based compensation expense 56 40
Amortization of discount and debt issuance costs 9 10
Reduction of right-of-use assets 159 163
Total losses on derivative instruments, net 539 258
Net cash provided by settlement of derivative instruments 71 24
Deferred taxes 38 (6)
Other, net (19) 2
Changes in operating assets and liabilities:    
Trade and other receivables (286) 430
Inventory (24) 81
Margin deposits 41 (17)
Other non-current assets (21) (6)
Accounts payable and accrued liabilities (93) (714)
Total deferred revenue (57) (42)
Total operating lease liabilities (152) (148)
Other, net (18) 27
Net cash provided by operating activities 1,228 1,246
Cash flows from investing activities    
Property, plant and equipment, net of proceeds on commissioning sales of LNG of $43 million and zero, respectively (623) (650)
Proceeds from Sale of Equity Method Investments 80 0
Other (6) (16)
Net cash used in investing activities (549) (666)
Cash flows from financing activities    
Proceeds from issuances of debt 125 1,497
Redemptions and repayments of debt (425) (150)
Distributions to non-controlling interests (200) (253)
Contributions from redeemable non-controlling interest 38 4
Payments related to tax withholdings for share-based compensation (44) (40)
Repurchase of common stock, inclusive of excise taxes paid (363) (1,189)
Dividends to stockholders (112) (105)
Other, net (16) (28)
Net cash used in financing activities (997) (264)
Effect of exchange rate changes on cash, cash equivalents and restricted cash and cash equivalents (4) (3)
Net increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents (322) 313
Cash, cash equivalents and restricted cash and cash equivalents—beginning of period 3,190 4,525
Cash, cash equivalents and restricted cash and cash equivalents—end of period $ 2,868 $ 4,838